Evidence map›Paper›PMID 39703205›Full record

ArticleRSC pharmaceutics2025

On-demand release of encapsulated ZnO nanoparticles and chemotherapeutics for drug delivery applications.

Josh E Eixenberger, Catherine B Anders, Rebecca Hermann, Katelyn Wada, Kongara M Reddy, Raquel J Montenegro-Brown, Daniel Fologea, Denise G Wingett

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Josh E EixenbergerBiomolecular Sciences Graduate Program, Boise State University Boise ID 83725 USA JoshEixenberger@boisestate.edu +208-426-2231.ORCID https://orcid.org/0000-0002-9816-7268
Catherine B AndersBiomolecular Sciences Graduate Program, Boise State University Boise ID 83725 USA JoshEixenberger@boisestate.edu +208-426-2231.
Rebecca HermannDepartment of Biological Sciences, Boise State, University Boise ID 83725 USA DeniseWingett@boisestate.edu +208-426-2921.
Katelyn WadaDepartment of Physics, Boise State University Boise ID 83725 USA.
Kongara M ReddyDepartment of Physics, Boise State University Boise ID 83725 USA.
Raquel J Montenegro-BrownBiomolecular Research Center, Boise State University Boise ID 83725 USA.
Daniel FologeaBiomolecular Sciences Graduate Program, Boise State University Boise ID 83725 USA JoshEixenberger@boisestate.edu +208-426-2231.
Denise G WingettBiomolecular Sciences Graduate Program, Boise State University Boise ID 83725 USA JoshEixenberger@boisestate.edu +208-426-2231.ORCID https://orcid.org/0000-0002-1784-9065

Funding

Women's health: interplay of maternal diet and key demographics on neurological health in the rural frontier and remote WestP20GM103408 · NIGMS · UNIVERSITY OF IDAHO · PI Carolyn Hovde Bohach · 2012 to 2026
$59.8M
VPS35 D620N inhibits autophagy through disrupted hyaluronic acid-CD44 signalingP20GM109095 · NIGMS · BOISE STATE UNIVERSITY · PI OCHOA-REPARAZ, JAVIER · 2014 to 2023
$22.7M
PAR04-122, Extramural Research Facilities Construction:*C06RR020533 · NCRR · BOISE STATE UNIVERSITY · PI RUDIN, MARK JOSEPH · 2010 to 2010
$4.0M
Preferential cytotoxic actions of metal oxide nanoparticles against cancerR15CA141358 · NCI · BOISE STATE UNIVERSITY · PI WINGETT, DENISE G · 2010 to 2010
$212k
NCI NIH HHS R15 CA141358NCRR NIH HHS C06 RR020533NIGMS NIH HHS P20 GM103408NIGMS NIH HHS P20 GM109095
6 · The paper itself

Abstract

Nanomedicines offer high promise for the treatment of various diseases, and numerous novel approaches using nanomaterials have been developed over the years. In this report, we introduce a new strategy utilizing ZnO nanoparticles (nZnO) to trigger the rapid release of lipid-encapsulated therapeutics upon photo-irradiation with UV light (365 nm).

Identifiers

PMID39703205
PMCPMC11650639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.